Infant born with deadly disease now thriving thanks to customized CRISPR treatment six months after birth

University of California, Berkeley·May 15

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

An infant born with a deadly disease is reportedly thriving after receiving a customized CRISPR treatment. The treatment, which may have been developed at UCLA, appears to have been successful, although there is some uncertainty about the specific details of the case, including the location where the treatment was administered and the exact nature of the disease being treated. The outcome is being described as a breakthrough, with the infant showing significant improvement.

Full coverage

‘Night and day’: Adventuring through childhood with newfound immune systems

Newsroom | UCLA·Mar 27

Experimental gene therapy treatment created at UCLA gives 'bubble girl' born with rare genetic disorder ADA-SCID a new life

ABC7 Los Angeles·Dec 10

Successful World First: Baby Treated with Personalized CRISPR Gene Therapy for Rare Disease is Now ‘Thriving’

Good News Network·Feb 3

Born at UC Berkeley: a breakthrough in the treatment of sickle cell disease

University of California, Berkeley·Jan 22

World's 1st patient treated with personalized CRISPR therapy at Children's Hospital of Philadelphia

6abc Philadelphia·May 16

7 world-changing UC innovations that emerged from federal research funding

University of California·Jul 15

Doctors Find Early Success With Partial Heart Transplants

The New York Times·Aug 27

Global immunization efforts have saved at least 154 million lives over the past 50 years

World Health Organization (WHO)·Apr 24

View original report at University of California, Berkeley ↗

Fetching the latest headlines…